This CME, CNE, and CPE-accredited educational program is designed to provide all members of the multidisciplinary care team knowledge and resources to successfully address practical issues and barriers faced in integration of immunotherapies into the treatment of renal cell carcinoma (RCC). The program will be presented in two formats: a live, on-site learning workshop and an audio-guided online course.
With the addition of checkpoint inhibitor immunotherapy to the treatment armamentarium for advanced bladder cancer, the care landscape for urothelial carcinoma is evolving. Keep the entire multidisciplinary care team up-to-date with information and resources from the ACCC education program on Optimizing Outcomes for Urothelial Carcinoma in the Community Setting. Two options for participation: a live, on-site learning workshop or as an audio-guided web course.
Could your cancer care team benefit from expert guidance and strategies for coping with common challenges in delivery of immunotherapy? ACCC is offering three upcoming workshop opportunities through the Best Practices for Implementing Cancer Immunotherapy in the Community education program.
Request to Host
Second in an education series, this program is offered in two formats: an on-demand audiocast and as an on-site live tumor board presentation. For this project, five ACCC Cancer Program members will have an opportunity to host Case Studies in IO: A Closer Look at Care Delivery on-site at their facility.
Organized around four case studies, the discussion will focus on current clinical evidence for optimal selection of immunotherapy and use of combination therapy. Topics covered include monitoring for and managing irAEs, care coordination and communication with non-oncology specialists, and assessment of institution- or practice-specific gaps in IO integration. Shared decision-making, reimbursement, and survivorship will also be discussed.